Whole-Cell Biocatalyst for Chemoenzymatic Total Synthesis of Rivastigmine

Whole-Cell Biocatalyst for Chemoenzymatic Total Synthesis of Rivastigmine

Biocatalytic processes are increasingly playing a key role in the development of sustainable asymmetric syntheses, which are central to pharmaceutical companies for the production of chiral enantiopure drugs. This work describes a simple and economically viable chemoenzymatic process for the product...

Full description

Bibliographic Details
Main Authors: Paola Vitale, Filippo Maria Perna, Gennaro Agrimi, Isabella Pisano, Francesco Mirizzi, Roberto Vito Capobianco, Vito Capriati
Format: Article
Language:English
Published: MDPI AG 2018-01-01
Series:Catalysts
Subjects:
rivastigmine
chemoenzymatic synthesis
bioreduction
whole-cell biocatalyst
(R)-arylethanols
baker’s yeast
deep eutectic solvents
Online Access:http://www.mdpi.com/2073-4344/8/2/55

Internet

http://www.mdpi.com/2073-4344/8/2/55

Similar Items